306 related articles for article (PubMed ID: 23351056)
1. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
Hansen PB
Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
3. Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.
Hansen PB; Poulsen CB; Walter S; Marcussen N; Cribbs LL; Skøtt O; Jensen BL
Hypertension; 2011 Sep; 58(3):464-70. PubMed ID: 21788606
[TBL] [Abstract][Full Text] [Related]
4. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.
Thuesen AD; Andersen H; Cardel M; Toft A; Walter S; Marcussen N; Jensen BL; Bie P; Hansen PB
Am J Physiol Renal Physiol; 2014 Aug; 307(4):F445-52. PubMed ID: 24966091
[TBL] [Abstract][Full Text] [Related]
6. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
Feng MG; Li M; Navar LG
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F331-7. PubMed ID: 14583435
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles.
Feng MG; Navar LG
Am J Physiol Renal Physiol; 2006 Apr; 290(4):F873-9. PubMed ID: 16263803
[TBL] [Abstract][Full Text] [Related]
8. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
Poulsen CB; Al-Mashhadi RH; Cribbs LL; Skøtt O; Hansen PB
Kidney Int; 2011 Feb; 79(4):443-51. PubMed ID: 21068717
[TBL] [Abstract][Full Text] [Related]
9. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
10. New Role of P/Q-type Voltage-gated Calcium Channels: From Transmitter Release to Contraction of Renal Vasculature.
Hansen PB
J Cardiovasc Pharmacol; 2015 May; 65(5):406-11. PubMed ID: 25469806
[TBL] [Abstract][Full Text] [Related]
11. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Baylis C; Qiu C; Engels K
Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels.
Hansen PB; Jensen BL; Andreasen D; Skøtt O
Circ Res; 2001 Sep; 89(7):630-8. PubMed ID: 11577029
[TBL] [Abstract][Full Text] [Related]
13. [Renal protective action of T-, L-, and N-type Ca channel blockers].
Hayashi K
Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
[No Abstract] [Full Text] [Related]
14. [Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].
Richard S; Virsolvy A; Fort A
Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):166-73. PubMed ID: 18565491
[TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
16. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
Ogimoto A; Higaki J
Clin Calcium; 2013 Apr; 23(4):569-74. PubMed ID: 23545747
[TBL] [Abstract][Full Text] [Related]
17. Voltage-dependent calcium channels.
Lacinová L
Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation.
Feng MG; Navar LG
Am J Nephrol; 2004; 24(6):641-8. PubMed ID: 15627720
[TBL] [Abstract][Full Text] [Related]
19. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
[TBL] [Abstract][Full Text] [Related]
20. [New calcium channel blockers for the treatment of hypertension].
Tamargo J
Hipertens Riesgo Vasc; 2017; 34 Suppl 2():5-8. PubMed ID: 29908667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
